Presentations

• “Drug dosing in dialysis: practical considerations” Utah Society of Health-System Pharmacists Meeting. Salt Lake City, Utah. Presentation, Presented, 09/2011.
• “Estimating renal function for drug dosing: CG versus MDRD” American Society of Health-System Pharmacists Midyear Meeting. Anaheim, California. Presentation, Presented, 12/2010.
• “Stages of confusion: diagnosis of patients with kidney disease” American College of Clinical Pharmacy Annual Meeting. Austin, Texas. Presentation, Presented, 10/2010.
• “Erythropoiesis-stimulating agents for anemia of CKD: to treat or not to treat” University of Utah Department of Family Medicine Grand Rounds. Salt Lake City, Utah. Presentation, Presented, 09/2010.
• “Medication considerations in CKD – beyond drug dosing” American College of Clinical Pharmacy Annual Meeting. Anaheim, California. Presentation, Presented, 10/2009.
• “Heparin-induced thrombocytopenia: implications for patients on dialysis” Invited presentation. Local chapter of the American Nephrology Nurses’ Association Meeting. Salt Lake City, Utah. Presentation, Presented, 09/2008.
• “Drug-induced renal dysfunction” Utah Society of Health-System Pharmacists Meeting. Salt Lake City, Utah. Presentation, Presented, 09/2007.
• “Pharmacologic management of renal osteodystrophy” Invited presentation. Local chapter of the American Nephrology Nurses’ Association Meeting. Salt Lake City, Utah. Presentation, Presented, 09/2007.
• “Pharmacotherapy: special considerations” Invited presentation. Clinical Nephrology Symposium, University of Wisconsin. Milwaukee, Wisconsin. Invited Talk/Keynote, Presented, 02/2007.
• “Anemia.” Invited presentation. Clinical Nephrology Symposium, University of Wisconsin. Milwaukee, Wisconsin. Invited Talk/Keynote, Presented, 02/2007.
• “Bone and phosphorus metabolism” Invited presentation. Clinical Nephrology Symposium, University of Wisconsin. Milwaukee, Wisconsin. Invited Talk/Keynote, Presented, 02/2007.
• “Management of hypertension in end stage renal disease” Invited presentation. Local Chapter of the American Nephrology Nurses’ Association Meeting. Salt Lake City, Utah. Presentation, Presented, 02/2007.
• “Dosing vancomycin during high-flux hemodialysis” Research Platform Presentation. American Society of Nephrology Annual Meeting. San Diego, California. Presentation, Presented, 11/2006.
• “ACEIs and ARBs in diabetic nephropathy” Utah Society of Health-System Pharmacists Meeting. Salt Lake City, Utah. Presentation, Presented, 09/2006.

Languages

• English, fluent.